Results 21 to 30 of about 5,062,336 (201)

Correlation of free T4 level at diagnosis and 03, 06 months after fixed dose radioiodine therapy among the hyperthyroid patients

Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2020
Our study aimed to identify the correlation between the presenting FT4 values and FT4 values after the radioiodine therapy. Patients, after 10 mCi fixed dose radioiodine therapy for thyrotoxicosis were followed up at 03, 06 months intervals at Nuclear ...
Sanooz Raheem, D. K. K. Nanayakkara
doaj   +1 more source

Should radioiodine now be first line treatment for Graves’ disease?

Thyroid Research, 2020
Background Radioiodine represents a cost-effective treatment option for Graves’ disease. In the UK, it is traditionally reserved for patients who relapse after initial thionamide therapy.
Onyebuchi E. Okosieme, Peter N. Taylor, Colin M. Dayan   +2 more
doaj   +1 more source

The Role of Radioiodine Therapy in Differentiated Thyroid Cancer Arising from Struma Ovarii: A Systematic Review. [PDF]

J Clin Med
Bellini P, Dondi F, Zilioli V, Gatta E, Cavadini M, Cappelli C, Viganò GL, Bertagna F.   +7 more
europepmc   +3 more sources

Factors influencing successful radioiodine therapy of thyroid [PDF]

Archive of Oncology, 2003
Background: Well-known fact is that the good surgical treatment, leaving only small residuals of thyroid tissue, is the outmost valid predictive factor of successful ablative radioiodine treatment. Assuming that all patients had state of the art surgical
Popadić Silvija M., Vojičić Jelena V., Peter Andrea, Malešević Milica Đ., Mihailović Jasna, Kermeci Katarina   +5 more
doaj   +1 more source

Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer

Diagnostics, 2022
We present an interesting image of a strikingly intense radioiodine accumulation of a histologically proven pancreatic adenocarcinoma mimicking metastasis of differentiated thyroid cancer in a 63-year-old woman with recurrence of papillary thyroid ...
Florian Rosar, Caroline Burgard, Maximilian Linxweiler, Phillip R. Stahl, Fadi Khreish, Samer Ezziddin   +5 more
doaj   +1 more source

Radioiodine therapy and Graves’ disease – Myths and reality

PLoS ONE, 2020
Introduction Autoimmune reactions in Graves’ disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles.
M. Płazińska, N. Sawicka-Gutaj, A. Czarnywojtek, Kosma Woliński, M. Kobylecka, Maria Karlińska, K. Prasek, M. Zgorzalewicz-Stachowiak, M. Borowska, P. Gut, M. Ruchała, L. Królicki   +11 more
semanticscholar   +1 more source

The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

Journal of Cancer, 2020
Objective: To investigate the correlation between the BRAF V600E gene mutation and clinicopathological features and thyroid function after iodine-131 treatment in patients with papillary thyroid cancer (PTC).
Junshang Ge, Jie Wang, Hui Wang, Xianjie Jiang, Q. Liao, Qian Gong, Yongzhen Mo, Xiaoling Li, Gui-yuan Li, W. Xiong, Jin Zhao, Zhaoyang Zeng   +11 more
semanticscholar   +1 more source

Dacryoendoscopic recanalization of lacrimal passage obstruction/stenosis after radioiodine therapy for differentiated thyroid carcinoma

American Journal of Ophthalmology Case Reports, 2022
Purpose: Radioiodine therapy, a standard treatment for differentiated thyroid carcinomas, is associated with several adverse events including lacrimal drainage system obstruction.
Daniela Inomata, Sujin Hoshi, Camila Pontes Bessa Campêlo Alcântara, Takahiro Hiraoka, Kuniharu Tasaki, Tetsuro Oshika, Suzana Matayoshi   +6 more
doaj   +1 more source

Salvage surgery for cervical radioiodine refractory 18F-FDG-PET positive recurrence of papillary thyroid cancer

Endocrine Connections, 2021
Purpose: Five percent of patients with differentiated thyroid cancer are diagnosed with radioiodine refractory relapse in the course of the disease. For isolated or oligometastatic cervical recurrence, resection or another local treatment is recommended.
C Chiapponi, H Alakus, M Faust, A M Schultheis, J Rosenbrock, M Schmidt   +5 more
doaj   +1 more source

Uptake and effect of radioiodine exposure on SKBR-3 cell lines

Majalah Kedokteran Andalas, 2019
Radioiodine has been known as an adjuvant therapy for thyroid cancer. Beside for thyroid cell, radioiodine is reported to be taken up by breast cell. It may be proposed as an alternative for breast cancer therapy.
Miftah Irramah, Yulia Kurniawati, VY Susilo, S Setiyowati, Aisyah Elliyanti   +4 more
doaj   +1 more source